Sachiko Matsumoto - Concepedia

Author

Sachiko Matsumoto

Dokkyo Medical University Saitama Medical Center ORCID

Also Known As

Matsumoto S., S Matsumoto, S. MATSUMOTO, S. Matsumoto, SACHIKO MATSUMOTO, Sachiko MATSUMOTO, Sachiko Matsumoto

133

Publications

2.1K

Citations

H-Index

141

Concepts

All Affiliations

Dokkyo Medical University Saitama Medical Center Tottori University The University of Osaka Dokkyo University Japan Advanced Institute of Science and Technology

About

Sachiko Matsumoto is an author at Dokkyo Medical University Saitama Medical Center specializing in medicine, biochemistry, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	25	720
2	Health Sciences	9	9	233
3	Engineering	8	8	291
4	Natural Sciences	6	6	196
5	Education	1	1	16

Sachiko Matsumoto

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Yucasin is a potent inhibitor of <scp>YUCCA</scp>, a key enzyme in auxin biosynthesis Takeshi Nishimura, Ken‐ichiro Hayashi, Hiromi Suzuki, The Plant Journal	2013	209
Bacterial Production of the Tunicate-Derived Antitumor Cyclic Depsipeptide Didemnin B Moriya Tsukimoto, Masato Nagaoka, Yoshiyuki Shishido, Journal of Natural Products Bioorganic ChemistryEngineeringAntibiotic AdjuvantSecondary MetaboliteBiosynthesis	2011	113
Aldosterone Blockade Attenuates Urinary Monocyte Chemoattractant Protein-1 and Oxidative Stress in Patients with Type 2 Diabetes Complicated by Diabetic Nephropathy Kohzo Takebayashi, Sachiko Matsumoto, Yoshimasa Aso, The Journal of Clinical Endocrinology & Metabolism	2006	108
The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy Sachiko Matsumoto, Kohzo Takebayashi, Yoshimasa Aso Metabolism InflammationMetabolic SyndromeRenal FunctionMedicineDiabetes	2006	65
Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: Association with increased plasminogen activator inhibitor-1 Yoshimasa Aso, Sachiko Matsumoto, Yukio Fujiwara, Metabolism ObesityThrombosisMetabolic SyndromePlasminogen Activator Inhibitor-1Cardiovascular Disease	2002	65
Expression of Polo-Like Kinase 1 (PLK1) Protein Predicts the Survival of Patients with Gastric Carcinoma Shingo Kanaji, Hiroaki Saito, Shunichi Tsujitani, Oncology	2006	62
A Functional Nitroxide Radical Displaying Unique Thermochromism and Magnetic Phase Transition Sachiko Matsumoto, Tsutomu Higashiyama, Hiroki Akutsu, Angewandte Chemie International Edition Magnetic PropertiesEngineeringLow-dimensional MagnetismHysteresis LoopMagnetic Resonance	2011	62
Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser1177/Thr497 of endothelial nitric oxide synthase in diabetic mice Sachiko Matsumoto, Michio Shimabukuro, Daiju Fukuda, Cardiovascular Diabetology	2014	61
A Small Molecule Inhibitor to Plasminogen Activator Inhibitor 1 Inhibits Macrophage Migration Atsuhiko Ichimura, Sachiko Matsumoto, Shinobu Suzuki, Arteriosclerosis Thrombosis and Vascular Biology	2013	52
Comparative analysis of the two-step reaction catalyzed by prokaryotic and eukaryotic phytochelatin synthase by an ion-pair liquid chromatography assay Naoki Tsuji, Shingo Nishikori, Osamu Iwabe, Planta Two-step ReactionBiotransformationBiochemistryNatural SciencesBiocatalysis	2005	47

Page 1